Treatment of etoposide combined with 15-deoxy∆12,14prostaglandin J2 exerted synergistic antitumor effects against renal cell carcinoma via peroxisome proliferatoractivated receptorγindependent pathways

Author：              

Publisher： Spandidos Publications

ISSN： 2049-9469

Source： Molecular and Clinical Oncology, Vol.2, Iss.2, 2014-01, pp. : 292-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prostaglandin J2 Inhibition of Mesangial Cell iNOS Expression

By Reilly C.M.   Oates J.C.   Sudian J.   Crosby M.B.   Halushka P.V.   Gilkeson G.S.  

Clinical Immunology, Vol. 98, Iss. 3, 2001-03 ,pp. : 337-345

Academic Press

Access to resources Recommend Favorite

Study of the effectiveness of firstline treatment in renal cell carcinoma

By              

Molecular and Clinical Oncology, Vol. 2, Iss. 6, 2014-01 ,pp. : 1167-1171

Spandidos Publications

Access to resources Recommend Favorite

Clinical and Immunomodulatory Effects of Celecoxib Plus Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients with COX-2 Tumor Immunostaining

By Schwandt Anita  

Journal of Clinical Immunology, Vol. 31, Iss. 4, 2011-08 ,pp. : 690-698

Springer Publishing Company

Access to resources Recommend Favorite

Transfusion-related acute lung injury (TRALI) following platelet transfusion in a patient receiving high-dose interleukin-2 for treatment of metastatic renal cell carcinoma

By Medeiros B.C.   Kogel K.E.   Kane M.A.  

Transfusion and Apheresis Science, Vol. 29, Iss. 1, 2003-08 ,pp. : 25-27

Elsevier

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-#947 and Its Ligands in the Treatment of Tumors in the Nervous System

By  

Current Stem Cell Research & Therapy, Vol. 11, Iss. 3, 2016-04 ,pp. : 208-215

Bentham Science Publishers

Access to resources Recommend Favorite